Top SMid Biotechnology Stocks: JPMorgan's Latest Picks for 2023
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowJPMorgan has identified several top SMid (small to mid-cap) biotechnology stocks for 2023. These stocks are noteworthy due to their potential for growth and investment opportunities in the biotechnology sector. Specific names or numbers have not been provided in the article, but JPMorgan's recommendations can influence market interest and trader decisions. Knowing which stocks are favored by analysts like JPMorgan may help ordinary investors make informed decisions in their portfolios.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About JPMorgan Chase & Co. (JPM)
JPMorgan Chase is the largest U.S. bank by assets, spanning consumer banking, investment banking, asset management, and payments.
The Financials sector covers banks, insurers and capital-markets firms at the center of the economy.
Earlier JPM news
- JPMorgan Chase (JPM) Stock Rises Following Upbeat Revenue Outlook
- Wall Street Strategies Cautious Amid Market Turbulence Signals
- Israel elections may impact shekel by 3%, says JPMorgan
- Former JPMorgan CEO Jes Staley Testifies on Epstein Abuse in July
- J.P. Morgan warns on Treasury bond buybacks amid $40 trillion debt
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
